Change of Name

Recorded: 2013-05-08 Received: 2013-05-08 Pages: 8

Assignor

AMYLIN PHARMACEUTICALS, INC.

Executed: 2012-08-08

Assignee

AMYLIN PHARMACEUTICALS, LLC

9360 TOWNE CENTRE DRIVE, SAN DIEGO, CA, 92121, UNITED STATES

Covered Properties (10)

Microcrystalline Y Receptor Agonists

Application: 13/809,136 →

Amylin and Amylin Agonists for Treating Psychiatric Diseases and Disorders

Application: 13/777,149 →

A Method of Lowering Cholesterol and Triglycerides by Administering Exendins

Application: 13/774,931 →

Neuromedin and FN-38 Peptides for Psychotic Diseases

Application: 13/651,130 →

Peptide YY and Peptide YY Agonists for Treatment of Metabolic Disorders

Application: 13/618,265 →

Mixing Tool

Application: 13/407,518 →

Exendins and Exendin Agonist Analogs to Regulate Gastrointestinal Motility

Application: 13/226,975 →

Methods of Treatment Using Exendin Peptides or Glp-1 Peptides

Application: 13/080,051 →

Methods for Affecting Body Composition

Application: 12/055,147 →

Use of Exendins and Agonists Thereof for the Treatment of Gestational Diabetes Mellitus

Application: 11/869,013 →